FDA Warning Letter — BP

Case 658466 — FEI 3014107005

The FDA took a Warning Letter action against BP on May 16, 2023 (Washington, DC). The action was issued by CTP and concerns tobacco products.

Action Details

Facility
BP
Date
May 16, 2023
Fiscal Year
2023
Product Type
Tobacco
Center
CTP
Location
Washington, DC (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.